95% CrI | Probability that Etoricoxib 30 mg Shows Clinical Improvement Relative to Comparator (≥ 10 mm VAS) | |||
---|---|---|---|---|
Comparator (mg) | Difference in CFB* | Low | High | |
nsNSAIDs | ||||
naproxen 1000 | -1.3 | -6.8 | 4.1 | 0.00 |
ibuprofen 2400 | -5.2 | -10.0 | -0.4 | 0.03 |
diclofenac 150 | 2.0 | -3.2 | 7.1 | 0.00 |
COX-2 selective NSAIDs | ||||
celecoxib 200 | 0.5 | -3.2 | 4.2 | 0.00 |
lumiracoxib 100 | -2.3 | -10.2 | 6.1 | 0.03 |
lumiracoxib 200 | -2.5 | -10.4 | 5.9 | 0.03 |
lumiracoxib 400 | -0.3 | -8.5 | 7.6 | 0.01 |